Pyxis Oncology to Join Fireside Chat at Jefferies Global Healthcare Conference

BOSTON, May 30, 2024 – Pyxis Oncology, Inc., a clinical-stage biotechnology company dedicated to developing innovative therapeutics for challenging cancer types, has announced that its President and CEO, Dr. Lara S. Sullivan, will be engaging in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled to take place on Thursday, June 6, 2024, at 9:00 AM Eastern Time in New York City. Additionally, the company's management team will conduct one-on-one meetings with investors during the conference.

For those unable to attend in person, a live webcast and a replay of Dr. Sullivan's presentation will be accessible through the Events & Presentations section of the Investor Relations page on Pyxis Oncology’s official website.

About Pyxis Oncology, Inc.

Pyxis Oncology, Inc. is committed to addressing some of the most challenging cancer cases through next-generation therapeutics. The company’s lead programs include PYX-201 and PYX-106, both aiming to offer new treatment avenues for solid tumors. PYX-201 is an antibody-drug conjugate (ADC) designed to target EDB+FN within tumor stroma, while PYX-106 is a fully human antibody that inhibits Siglec-15, a protein involved in suppressing T-cell functions. These therapies are currently being tested in Phase 1 clinical trials across various solid tumor indications.

Pyxis Oncology’s therapeutic approach focuses on not only directly targeting and killing cancer cells but also addressing the underlying mechanisms that allow tumors to grow uncontrollably and evade the immune system. Their ADC and immuno-oncology (IO) programs utilize innovative strategies to combat tumors that are resistant to existing treatments.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!